LENZ vs JBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

LENZ

44.0
AI Score
VS
JBIO Wins

JBIO

52.1
AI Score

Investment Advisor Scores

LENZ

44score
Recommendation
HOLD

JBIO

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric LENZ JBIO Winner
Net Income -82.13M -40.37M JBIO
Operating Income -91.14M -43.45M JBIO
ROE -28.9% -13.6% JBIO
ROA -26.8% -12.6% JBIO
Total Assets 305.88M 319.43M JBIO
Cash 25.18M 55.09M JBIO
Current Ratio 14.23 14.29 JBIO
Free Cash Flow -70.00M -24.28M JBIO

Relative Price Performance (Last 90 Days)

LENZ 1M: -11.2% · 3M: -46.4% JBIO 1M: -2.7% · 3M: -15.5%

Current Technical Phase

LENZ

Markdown
Sell / avoid

Price below a falling SMA50 (slope -17.6%), weak momentum, RSI 39

RSI (14): 39.0 · Price: $4.97

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 52.5 · Price: $20.72

Fundamentals Snapshot

Metric LENZ JBIO
Market Cap
Forward P/E -1.6 -8.7
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.9%
Operating Margin -23.2% 0.0%
EPS -3.53 -2.72
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, JBIO is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.